Hic-5 regulates an epithelial program mediated by PPARgamma
about
Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activityThe role of peroxisome proliferator-activated receptors in carcinogenesis and chemopreventionPRDM16 controls a brown fat/skeletal muscle switchChemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancerPaxillin enables attachment-independent tyrosine phosphorylation of focal adhesion kinase and transformation by RAS.PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinomaERK8 down-regulates transactivation of the glucocorticoid receptor through Hic-5.White adipose tissue development in zebrafish is regulated by both developmental time and fish size.Thioredoxin-mediated negative autoregulation of peroxisome proliferator-activated receptor alpha transcriptional activity.Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.The diverse biofunctions of LIM domain proteins: determined by subcellular localization and protein-protein interaction.Hic-5, an adaptor-like nuclear receptor coactivator.Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel diseasePeroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC1alpha) is a metabolic regulator of intestinal epithelial cell fate.Increased acetylation in the DNA-binding domain of TR4 nuclear receptor by the coregulator ARA55 leads to suppression of TR4 transactivationCyclin D1 represses gluconeogenesis via inhibition of the transcriptional coactivator PGC1αSelective coregulator function and restriction of steroid receptor chromatin occupancy by Hic-5.N-Acetylfarnesylcysteine is a novel class of peroxisome proliferator-activated receptor γ ligand with partial and full agonist activity in vitro and in vivo.Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancerThe toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation.CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.Synergy between PPARgamma ligands and platinum-based drugs in cancer.Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J micePeroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.Dietary modulation of inflammation-induced colorectal cancer through PPARγ.Pathophysiological Roles of PPARgamma in Gastrointestinal Epithelial CellsCurrent understanding of the role of PPARγ in gastrointestinal cancersHic-5 is a transcription coregulator that acts before and/or after glucocorticoid receptor genome occupancy in a gene-selective manner.Molecular Mechanisms and Genome-Wide Aspects of PPAR Subtype Specific Transactivation.When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription.Functional interaction between peroxisome proliferator-activated receptor gamma and beta-cateninGlucocorticoid receptor binding to chromatin is selectively controlled by the coregulator Hic-5 and chromatin remodeling enzymes.Rosiglitazone Induces Mitochondrial Biogenesis in Differentiated Murine 3T3-L1 and C3H/10T1/2 AdipocytesTranscriptional Regulation of Human Cytosolic Sulfotransferase 1C3 by Peroxisome Proliferator-Activated Receptor γ in LS180 Human Colorectal Adenocarcinoma CellsMicroRNA-130b promotes cell proliferation and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma cells.Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.
P2860
Q24322799-3F2A4D2B-1E55-432C-A1B5-5274ADA8C7EDQ24601222-F9F2C88B-3807-4AC7-9B12-F87922163504Q24657178-7DE786DC-1189-43B1-81E9-29D309BA9B26Q27026428-91088FED-04B4-498B-B6BB-D461D664FAECQ30424126-B1DBF8A9-2566-4A58-B0A2-C760A293E654Q33235601-ECD57FF0-2985-48BE-92E5-896E02FFEE95Q33240390-490D57F8-5594-459D-96C1-42B4D32B2A99Q34469369-FAC72F96-2633-4516-9102-F98B245AC446Q34483693-B0EE7A32-9A08-436F-A33F-F59420A36407Q34495620-089C769A-6E5F-414B-BCEB-32D295D6C6A2Q34662765-03C4761A-55CE-4E44-B53E-83CD0AE0C85DQ34803398-2A8B20F6-48CB-43C6-A252-9D68A4AE7FCDQ34804346-BDB4A975-C7AE-4DA4-852D-3609B18294C4Q34836415-597C424F-B026-403C-A2BF-BD13FF382EBFQ35065122-B30517A7-32E8-430D-9F2E-3F5A2EB73F99Q35360473-E61EAA87-3570-4173-9586-D3D78F650BEBQ35555689-6701385A-25D4-4736-BFDE-83C9C1E7D124Q35842216-19658BD3-A54C-4CB6-AB7B-DF2576AA61B8Q35923246-75E8388A-F017-4211-970C-3A3F35A8122EQ36238973-36756DEF-370D-46F7-9F7F-A297337665CAQ36328530-6F6C4E8C-9B0B-4FB5-B12F-38C8FF78DF64Q36421428-BC1260A3-3141-4485-BFCF-70A5F6FC8C7CQ36497247-127B91ED-9DFD-4B00-A328-10759CFF90BCQ36930841-B6DA4296-710D-4506-8B81-DAE57777640CQ36972748-8E2A4BC3-283E-4EC6-803B-9C15603B9410Q37142538-0FE8D3B7-3C52-430E-806A-43BB646ED5AEQ37162405-98F07968-0CF4-442A-9B2C-B4DEB5BECE4BQ37166674-DD3E9CF8-1316-4F59-A242-D28DAC1A193AQ37211826-4882559C-36EE-4343-8747-8EB5510B6E2FQ37626440-187025AE-2B9A-45CE-ADFE-6A155A40A96AQ37659745-32A003B3-AB4B-4BCC-B92D-01F43218C78AQ37791438-47BC3EC0-D597-4FD3-AC6F-59BFF22FA052Q37933675-6BCD3C27-F498-47F9-BBEB-07CFF156809AQ38318721-6855107B-5EFB-49E7-848F-619DE65E6235Q38408437-C6611FFD-7DCD-43BE-AF23-EA8D30CB8B10Q38708719-F463C6CF-3F9C-4533-86B9-02290ACD0A39Q38729861-422B03EB-A5D6-494F-AC27-E14A64B1C980Q38749869-FE6369EB-CDB8-465D-84A5-7CBB21235FCCQ38774875-B49B9AA2-0CB1-44C2-9EA7-11C84C89A957Q39370938-BFA1B84C-ED36-4EA1-8B4D-BA4F8DCC1BC9
P2860
Hic-5 regulates an epithelial program mediated by PPARgamma
description
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Februar 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/02/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/02/01)
@nl
наукова стаття, опублікована в лютому 2005
@uk
مقالة علمية (نشرت في فبراير 2005)
@ar
name
Hic-5 regulates an epithelial program mediated by PPARgamma
@ast
Hic-5 regulates an epithelial program mediated by PPARgamma
@en
Hic-5 regulates an epithelial program mediated by PPARgamma
@nl
type
label
Hic-5 regulates an epithelial program mediated by PPARgamma
@ast
Hic-5 regulates an epithelial program mediated by PPARgamma
@en
Hic-5 regulates an epithelial program mediated by PPARgamma
@nl
prefLabel
Hic-5 regulates an epithelial program mediated by PPARgamma
@ast
Hic-5 regulates an epithelial program mediated by PPARgamma
@en
Hic-5 regulates an epithelial program mediated by PPARgamma
@nl
P2093
P2860
P3181
P356
P1433
P1476
Hic-5 regulates an epithelial program mediated by PPARgamma
@en
P2093
Elisabetta Mueller
Geoffrey D. Girnun
Jeffrey D. Szwaya
Liqiang Tou
Ramesh A. Shivdasani
Stavit Drori
P2860
P304
P3181
P356
10.1101/GAD.1240705
P577
2005-02-01T00:00:00Z